Author name: Dave Cundiff, MD, MPH, FASAM

Dr. Cundiff is board-certified in Addiction Medicine and in Public Health & General Preventive Medicine. He earned his MD at the University of Pennsylvania and his MPH at Johns Hopkins, and serves on the American Medical Association's Council on Science and Public Health. He is a Fellow of the American Society of Addiction Medicine and a national mentor on buprenorphine treatment through the Providers Clinical Support System. At Crestview, he leads the medical team, oversees medication management, and advises on clinical policy and practice.

a man speaking in front of a group about alcohol liver damage

National Alcohol and Other Drug-Related Birth Defects Awareness Week

Spreading awareness regarding the dangers of using substances during pregnancy is important. According to the National Council on Alcoholism and Drug Dependence (NCADD), too many women use drugs while they're pregnant. The NCADD launched National Alcohol and Other Drug-Related Birth Defects Awareness Week to spread awareness about this problem. The NCADD wants to help soon-to-be

National Alcohol and Other Drug-Related Birth Defects Awareness Week Read More »

Medication Assisted Treatment for Opioid Addiction

When people seek treatment for opioid addiction, they have many treatments to consider. No matter which programs they choose, they should include treatment with medication. Medication assisted treatment for opioid addiction will help them during and after withdrawal. In order to understand the importance of this program, though, they have to understand how it works.

Medication Assisted Treatment for Opioid Addiction Read More »

Accessibility Toolbar

Scroll to Top